Non-glycaemic benefits of medications for people living with type 2 diabetes
There have been numerous advancements in the pharmacological management of type 2 diabetes (T2D) in recent years. Historically, the foundation of T2D...
There have been numerous advancements in the pharmacological management of type 2 diabetes (T2D) in recent years. Historically, the foundation of T2D...
Two of the greatest public health concerns in the developed world are obesity and ageing.1 Obesity is classified as body mass index [BMI] ³...
Treatment Induced Neuropathy of Diabetes (TIND), also known as insulin neuritis, was first described in...
Glucocorticoids are an effective anti-inflammatory and immunosuppressant used in the treatment of many medical conditions, including COVID-19. The use...
Osteoporosis is a systemic condition in which low bone mass and impairments in bone microstructure leads to increased skeletal fragility and a...
Diabetic ketoacidosis (DKA) is a severe and life-threatening complication of Type 1 Diabetes (T1D). A recent review of...
Diabetes is the world’s fastest growing chronic condition,1 so it has never been more important to understand the complications and...
Managing diabetes during an intercurrent illness is challenging, and education regarding ‘Sick Day Management’ remains a crucial aspect of diabetes...
Coeliac disease (CD) co-exists with type 1 diabetes (T1D) more commonly than CD alone within the general population...